Topical tacrolimus - A role in atopic dermatitis?

Drug and Therapeutics Bulletin

Volumn 40, Issue 10, 2002, Pages 73-75

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALCLOMETASONE DIPROPIONATE; BETAMETHASONE VALERATE; CORTICOSTEROID; DILTIAZEM; DRUG VEHICLE; EMOLLIENT AGENT; ERYTHROMYCIN; HYDROCORTISONE ACETATE; HYDROCORTISONE BUTYRATE; IMMUNOSUPPRESSIVE AGENT; KETOCONAZOLE; MACROLIDE; STEROID; TACROLIMUS; VACCINE; DERMATOLOGICAL AGENT;

ADOLESCENT; ADULT; AGE; AGED; ALLOGRAFT; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ALCOHOL INTERACTION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG RESPONSE; DRUG USE; ERYTHEMA; FEMALE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY TRANSPLANTATION; LICENCE; LIVER TRANSPLANTATION; MALE; OINTMENT; PRURITUS; SKIN MANIFESTATION; INTRADERMAL DRUG ADMINISTRATION; REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; CHILD; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; OINTMENTS; TACROLIMUS; TREATMENT OUTCOME;

EID: 0036781388     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2002.401073     Document Type: Article

References (19)

1. Charman C. Clinical evidence. Atopic eczema. BMJ 1999; 318: 1600-4.
2. Williams HC, Wüthrich B. The natural history of atopic dermatitis. In: Williams HC (Ed). Atopic dermatitis. The epidemiology, causes and prevention of atopic eczema. Cambridge: Cambridge: University Press, 2000.
3. Bos JD, Smitt JHS. Atopic dermatitis. J Eur Acad Dermatol Venerol 1996; 7: 101-14.
4. Lawrence ID. Tacrolimus (FK506): experience in dermatology. Dermatol Ther 1998; 5: 74-84.
5. Protopic 0.1% Summary of product characteristics, UK. Fujisawa, Feb 2002.
6. Protopic 0.03% Summary of product characteristics, UK. Fujisawa, Feb 2002.
7. Boguniewicz M et al. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. J Allergy Clin Immunol 1998; 102: 637-44.
8. Ruzicka T et al. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med 1997; 337: 816-21.
9. Hanifin JM et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, Efficacy. J Am Acad Dermatol 2001; 44: S28-38.
10. Paller A et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 2001; 44: S47-57.
11. Reitamo S et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 539-46.
12. Reitamo S et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 547-55.
13. Williams H. New treatments for atopic dermatitis. BMJ 2002; 324: 1533-4.
14. Reitamo S et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 1998; 111: 396-8.
15. Kawakami T et al. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation. Dermatology 2001; 203: 32-7.
16. Drake L et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 2001; 44: S65-72.
17. Kang S et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001; 44: S58-64.
18. Reitamo S et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. Arch Dermatol 2000; 136: 999-1006.
19. Soter NA et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patient: Part II, Safety. J Am Acad Dermatol 2001; 44: S39-46.